Supplier News Breaks Archives
GlaxoSmithKline's Flonase Allergy Relief nasal spray is slated to go over the counter starting next year.
The Food and Drug Administration has approved Purdue Pharma's Targiniq ER, an opioid painkiller with abuse-deterrent properties.
Timothy Toll has been appointed chief executive officer at Pharmavite LLC.
The Food and Drug Administration has accepted Sandoz's Biologics License Application for filgrastim, which was filed under the new biosimilar pathway created in the Biologics Price Competition and Innovation Act of 2009.
Camber Pharmaceuticals has hired two new executives in key sales and marketing positions.
Kirby Lester announced that its KL1Plus medication dispensing device now includes streamlined functionality to perform a trackable double-count for any prescription coming out of a vial-filling robot.
Sanofi Pasteur has released the first lots of its Fluzone influenza vaccine for the 2014-15 flu season to the Food and Drug Administration for distribution.
McKesson Pharmacy Systems and Automation (MPS&A) is launching the largest software release for its Pharmaserv pharmacy management system in four years.
Campbell Soup Co. plans to launch more than 200 new products in fiscal 2015 to meet consumers' changing tastes, preferences and needs.
Teva Pharmaceutical Industries Ltd. has completed its $200 million deal to acquire Labrys Biologics Inc., which focuses on treatments for migraine headaches
Sandoz Inc. has entered an agreement with Anacor Pharmaceuticals Inc. to obtain exclusive rights to commercialize Kerydin topical solution (5%), a toenail fungal infection medication, in the United States.
Newell Rubbermaid Inc. plans to acquire Ignite Holdings LLC, a designer and marketer of durable beverage containers, from private equity firm North Castle Partners for $308 million.
Lannett Co. has signed an agreement with Symplmed Inc. to be the exclusive U.S. distributor of an authorized generic version of Aceon, a hypertension medication.